kpv
KPV, explained.
KPV is one of the smallest peptides studied in inflammation research — a three-amino-acid fragment of a natural hormone, investigated in cell and animal models of gut, immune, and skin inflammation. PepEasy is a clean place to understand what the research describes, grounded in citations.
Educational only — not medical advice. Consult a qualified licensed provider.
KPV is a synthetic tripeptide of lysine, proline, and valine — the C-terminal tail (residues 11–13) of the hormone α-MSH. In laboratory studies it retains anti-inflammatory activity without the parent hormone's tanning or appetite effects, and it is studied mainly in cell and animal models of gut, immune, and skin inflammation. It is not FDA-approved and is sold as a research chemical.
What KPV is
KPV is a synthetic tripeptide — just three amino acids, lysine, proline, and valine (Lys-Pro-Val). Those three residues are the tail end of alpha-melanocyte-stimulating hormone (α-MSH), an anti-inflammatory peptide the body produces, specifically its 11th through 13th residues. Researchers became interested in this fragment because much of α-MSH's anti-inflammatory activity in laboratory models appears concentrated in that short tail, while KPV lacks the parts of the hormone associated with skin tanning and appetite changes. It is also unusual among peptides in that it shows activity in oral gut-inflammation models, where most peptides are digested. KPV is not an approved drug; it is sold as a research chemical and is described in the literature as a component of some multi-peptide blends, sometimes labeled GLOW or KLOW.
How KPV is thought to work
KPV's mechanism, as described in cell and rodent studies, is understood as reducing inflammatory signaling through more than one route. The most-cited mechanism is that KPV enters cells and inhibits IκB kinase, which dampens the NF-κB pathway — a regulator of pro-inflammatory genes. With that pathway suppressed, cells produce fewer inflammatory messengers such as TNF-α and IL-6 in these models. KPV also interacts with melanocortin receptors (MC1R and MC3R), associated in the literature with both anti-inflammatory and antimicrobial activity. In the gut specifically, immune and intestinal cells appear to take KPV up through the peptide transporter PepT1, which researchers cite to explain local activity in the intestinal lining and oral activity. α-MSH-derived peptides have also shown direct activity against some bacteria and fungi in the lab. This is mechanism worked out largely in-vitro and in animals — human pharmacology, bioavailability, and dosing are not well characterized.
Areas of research interest
- Gut inflammation — its largest evidence base, with reduced inflammation reported in mouse colitis models, including oral dosing
- Immune modulation — effects on inflammatory immune-cell activity studied in models
- Skin inflammation — investigated as the anti-inflammatory component in blends such as GLOW and KLOW
- General anti-inflammatory signaling — NF-κB and cytokine suppression reported in cell studies
- Combination studies — examined alongside other peptides such as BPC-157 in gut-focused research
Safety & legal status
Human safety data for KPV is limited — tolerability is inferred from small models rather than chronic human use, and anecdotal reports are not systematically documented. Because it is distributed as a research chemical, identity and purity can vary, and tiny peptides like KPV can be under-filled or mislabeled. None of this is medical advice — consult a qualified licensed provider about your own situation. On legal status, KPV is not FDA-approved for human use. It is on the agenda of the FDA's Pharmacy Compounding Advisory Committee (PCAC) meeting on July 23, 2026, where KPV free base and acetate are being considered for the 503A bulks list for wound healing and inflammatory uses — but that would only determine eligibility for pharmacy compounding, not drug approval, and status varies by country.
KPV vs BPC-157
| KPV | BPC-157 | |
|---|---|---|
| Main focus | Anti-inflammatory (NF-κB) signaling | Tissue repair and angiogenesis |
| Origin | C-terminal fragment of α-MSH (Lys-Pro-Val) | Stable gastric pentadecapeptide derivative |
| Research area | Gut, immune & skin inflammation | Gut, tendon/tissue healing |
| Routes reported | Oral, subcutaneous, topical | Oral and subcutaneous |
| Evidence level | Preclinical (cell/animal models) | Preclinical / anecdotal |
| Studied together | Examined in gut-focused research rather than chosen one-or-the-other | Examined in gut-focused research rather than chosen one-or-the-other |
Frequently asked
What are KPV's side effects?+
Human safety data is limited, so most of what's described comes from small models and anecdote rather than systematic study. A practical concern often raised is sourcing quality — research-grade peptides can be under-filled or mislabeled. None of this is medical advice; consult a qualified licensed provider.
What is KPV studied for?+
KPV is studied mainly as an anti-inflammatory peptide. Its largest evidence base is in gut-inflammation and colitis models, and it is also investigated for immune modulation and skin inflammation (it appears as the anti-inflammatory component in blends like GLOW and KLOW). This evidence is mostly preclinical — cell and animal studies — so human relevance is not established.
Is KPV a steroid?+
No, KPV is not a steroid — it is a three-amino-acid fragment of the natural hormone α-MSH studied for effects on inflammatory signaling, not anabolic pathways. Human data is limited and it is not approved for human use, so its long-term safety is not established. Consult a qualified licensed provider about your own situation.
Is KPV FDA approved?+
No. KPV is not FDA-approved for human use and is sold as a research chemical. It is on the agenda of the FDA's Pharmacy Compounding Advisory Committee meeting on July 23, 2026 (KPV free base/acetate, for wound healing and inflammatory uses), but that would only address pharmacy-compounding eligibility — it is not drug approval, and status varies by country.
Everything peptides, made easy.
Join PepEasy and get the tools, the knowledge, and the care — in one place.
Explore more